Concord Biotech Limited (CONCORDBIO.NS)
INR 2147.65
(-1.18%)
INR 2147.65
(-1.18%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 7.56 Billion INR | 17.06% |
| 2022 | 6.72 Billion INR | 26.85% |
| 2021 | 5.3 Billion INR | 9.67% |
| 2020 | 4.83 Billion INR | 29.25% |
| 2019 | 3.74 Billion INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 1.67 Billion INR | -27.21% |
| 2023 Q2 | 2.09 Billion INR | 35.65% |
| 2023 Q4 | 2.3 Billion INR | 18.8% |
| 2023 Q3 | 1.93 Billion INR | -7.53% |
| 2023 FY | 7.87 Billion INR | 17.06% |
| 2023 Q1 | 1.54 Billion INR | -12.53% |
| 2022 Q3 | 1.91 Billion INR | 54.29% |
| 2022 FY | 6.72 Billion INR | 26.85% |
| 2022 Q4 | 1.76 Billion INR | -7.68% |
| 2022 Q2 | 1.23 Billion INR | 0.0% |
| 2021 FY | 5.3 Billion INR | 9.67% |
| 2020 FY | 4.83 Billion INR | 29.25% |
| 2019 FY | 3.74 Billion INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Biocon Limited | 91.73 Billion INR | 91.754% |
| Blue Jet Healthcare Limited | 3.15 Billion INR | -139.442% |
| Dishman Carbogen Amcis Limited | 4.9 Billion INR | -54.257% |
| Jubilant Ingrevia Limited | 9.16 Billion INR | 17.472% |
| Lyka Labs Limited | 145.95 Million INR | -5082.85% |
| Panacea Biotec Limited | 1.42 Billion INR | -429.836% |
| Piramal Pharma Limited | 24.47 Billion INR | 69.088% |
| SMS Lifesciences India Limited | 329.57 Million INR | -2195.214% |
| Supriya Lifescience Limited | 2.65 Billion INR | -185.258% |
| Syngene International Limited | 12.43 Billion INR | 39.183% |
| TAKE Solutions Limited | 183.42 Million INR | -4024.127% |
| Zota Health Care Limited | 332.52 Million INR | -2174.845% |